Streetbeat News

Analyst Ratings

ANGO

Canaccord Genuity analyst William Plovanic maintains a Buy rating on AngioDynamics but lowers the price target from $13 to $12.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 2:43 pm

STZ

Constellation Brands (NYSE:STZ) reported strong Q2 earnings, beating EPS expectations but missing sales consensus. Analysts express concerns about the company's performance in the latter half of the year, citing macroeconomic pressures and category sluggishness. Despite these concerns, some analysts maintain positive ratings, highlighting strong volume growth and potential for improvement.

Portfolio Pulse from Priya Nigam

October 04, 2024 | 2:41 pm

PENN

JMP Securities analyst Jordan Bender has reiterated a Market Perform rating on PENN Entertainment, indicating a neutral stance on the stock.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 2:40 pm

TXRH

Truist Securities has maintained a Buy rating on Texas Roadhouse and increased the price target from $196 to $202, indicating confidence in the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 2:32 pm

GSHD

Truist Securities has maintained a Hold rating on Goosehead Insurance while raising the price target from $65 to $80, indicating a positive outlook on the company's stock performance.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 2:30 pm

BHP

CB

DIN

GEV

LI

Several top Wall Street analysts have downgraded their ratings for major companies, including GE Vernova, Li Auto, Chubb Limited, Dine Brands Global, and BHP Group. Despite downgrades, some price targets were raised, indicating mixed sentiment.

Portfolio Pulse from Avi Kapoor

October 04, 2024 | 2:25 pm

STZ

Roth MKM analyst Bill Kirk has reiterated a Buy rating on Constellation Brands (NYSE:STZ) and maintained a price target of $298.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 2:23 pm

SNAP

Wells Fargo analyst Ken Gawrelski maintains an Overweight rating on Snap but lowers the price target from $15 to $14.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 2:20 pm